BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33085742)

  • 1. BIX-01294-enhanced chemosensitivity in nasopharyngeal carcinoma depends on autophagy-induced pyroptosis.
    Li Q; Wang M; Zhang Y; Wang L; Yu W; Bao X; Zhang B; Xiang Y; Deng A
    Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1131-1139. PubMed ID: 33085742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIX-01294 enhanced chemotherapy effect in gastric cancer by inducing GSDME-mediated pyroptosis.
    Deng BB; Jiao BP; Liu YJ; Li YR; Wang GJ
    Cell Biol Int; 2020 Sep; 44(9):1890-1899. PubMed ID: 32437063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobaplatin induces pyroptosis through regulating cIAP1/2, Ripoptosome and ROS in nasopharyngeal carcinoma.
    Chen Z; Xu G; Wu D; Wu S; Gong L; Li Z; Luo G; Hu J; Chen J; Huang X; Chen C; Jiang Z; Li X
    Biochem Pharmacol; 2020 Jul; 177():114023. PubMed ID: 32413426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIX-01294, a G9a inhibitor, suppresses cell proliferation by inhibiting autophagic flux in nasopharyngeal carcinoma cells.
    Li Q; Wang L; Ji D; Bao X; Tan G; Liang X; Deng P; Pi H; Lu Y; Chen C; He M; Zhang L; Zhou Z; Yu Z; Deng A
    Invest New Drugs; 2021 Jun; 39(3):686-696. PubMed ID: 33387131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 6. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of autophagy inhibitors combined with cisplatin against cisplatin-resistant nasopharyngeal cancer cells.
    Yin W; Xu J; Mao Y
    Biochem Cell Biol; 2021 Jun; 99(3):322-329. PubMed ID: 34038188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of autophagy by chloroquine makes chemotherapy in nasopharyngeal carcinoma more efficient.
    Aga T; Endo K; Tsuji A; Aga M; Moriyama-Kita M; Ueno T; Nakanishi Y; Hatano M; Kondo S; Sugimoto H; Wakisaka N; Yoshizaki T
    Auris Nasus Larynx; 2019 Jun; 46(3):443-450. PubMed ID: 30514592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells.
    Yu J; Li S; Qi J; Chen Z; Wu Y; Guo J; Wang K; Sun X; Zheng J
    Cell Death Dis; 2019 Feb; 10(3):193. PubMed ID: 30804337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
    Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
    BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
    Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
    J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Caspase-1/GSDMD-mediated pyroptosis in Taxol-induced cell death and a Taxol-resistant phenotype in nasopharyngeal carcinoma regulated by autophagy.
    Wang X; Li H; Li W; Xie J; Wang F; Peng X; Song Y; Tan G
    Cell Biol Toxicol; 2020 Oct; 36(5):437-457. PubMed ID: 31993881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
    Huang Y; Tian Y; Zhao Y; Xue C; Zhan J; Liu L; He X; Zhang L
    Cancer Commun (Lond); 2018 May; 38(1):15. PubMed ID: 29764490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy related 4B, upregulated by HIF-1α, attenuates the sensitivity to cisplatin in nasopharyngeal carcinoma cells.
    Huang J; Li HB; Yu S; Yuan F; Lou ZP
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4793-4802. PubMed ID: 32432742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
    Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX
    Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation.
    Zhang CC; Li CG; Wang YF; Xu LH; He XH; Zeng QZ; Zeng CY; Mai FY; Hu B; Ouyang DY
    Apoptosis; 2019 Apr; 24(3-4):312-325. PubMed ID: 30710195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity.
    Shen X; Wang H; Weng C; Jiang H; Chen J
    Cell Death Dis; 2021 Feb; 12(2):186. PubMed ID: 33589596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis.
    Zhou B; Zhang JY; Liu XS; Chen HZ; Ai YL; Cheng K; Sun RY; Zhou D; Han J; Wu Q
    Cell Res; 2018 Dec; 28(12):1171-1185. PubMed ID: 30287942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
    Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
    Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.